Once Upon a Farm, PBC (OFRM) is a Berkeley, California-based producer of organic, refrigerated baby food pouches, meals, and snacks for infants, toddlers, and young children. Co-founded by actress Jennifer Garner, the company went public on the New York Stock Exchange in February 2026 at an IPO price of $18.00 per share. The stock initially surged to its 52-week high of $27.00 but has since retreated significantly, now trading below its IPO price at approximately $16.70. With a market capitalization of roughly $701 million and trailing twelve-month revenue of $288.17 million, the company operates in the consumer defensive packaged foods sector.
The $25 stock price target has become a focal point for OFRM investors largely because it sits near the center of Wall Street's consensus analyst forecast. According to S&P Global data, nine analysts covering the stock maintain an average twelve-month price target of approximately $25.25, with individual estimates ranging from a low of $19 (Barclays) to a high of $43 (Goldman Sachs). Reaching $25 would represent a recovery above the IPO price, a roughly 50% gain from current levels, and would place the stock near its all-time highs. For early IPO investors who bought at $18 and held through the decline, $25 also represents a psychologically significant round number that would validate the long-term growth narrative.
The bull case for OFRM reaching $25 rests primarily on the company's exceptional revenue trajectory. In fiscal 2025, revenue grew 53.49% to $240.68 million, and the most recent quarter delivered 43.7% organic sales growth, well above consensus estimates of 28%. Management raised its 2026 sales growth guidance to 30%-34% following the strong quarter, driven by momentum in baby snacks and a national club retail promotion.
Central to the growth story is the company's branded cooler program, which deploys refrigerated displays in baby aisles at major retailers including Target, Walmart, Kroger, and Whole Foods. The strategy mirrors a playbook successfully executed by Freshpet in the pet food category. With household penetration at only 5.8% and a long-term target of 10% or higher, the addressable market remains substantially underpenetrated. JPMorgan, which maintains an Overweight rating and recently raised its price target to $26, projects growth rates of 27% in 2026 and 35% in 2027, citing the cooler rollout and expansion into kids' snacks as durable catalysts.
Despite impressive top-line momentum, OFRM remains unprofitable on both a net income and EBITDA (earnings before interest, taxes, depreciation, and amortization) basis. The company guided to just $2 million to $4 million in EBITDA for 2026, translating to razor-thin margins of roughly 1%. Management's decision to reinvest sales upside into marketing and infrastructure—while strategically sound for long-term brand building—keeps near-term profitability suppressed and limits valuation multiple expansion.
Equally concerning is the trend in analyst sentiment. Since the March 2026 initiation period, when firms like Goldman Sachs set targets as high as $43, several major banks have steadily reduced their price objectives. TD Cowen cut from $26 to $18, Barclays moved from $25 to $18 before recently ticking up to $19, and Evercore ISI lowered from $26 to $23. This pattern of downward revisions signals growing caution around execution risks, margin trajectory, and competitive pressures in the organic nutrition segment.
From a technical analysis perspective, OFRM has established a well-defined trading range since its IPO. The $14.00 level has served as firm support, with the stock bouncing from that zone multiple times, including during July 2026. On the upside, $24.37 marks an important resistance level, with the 52-week high of $27.00 representing the next major overhead barrier. To reach $25, the stock would need to first reclaim the declining trendline from the post-IPO highs and then clear the $24.37 resistance zone—a move that would require sustained buying volume and positive fundamental catalysts.
The stock currently trades below its 50-day simple moving average of approximately $17.80, reflecting the near-term bearish pressure that must be resolved before any meaningful advance toward $25 can materialize.
Wall Street remains divided but leans cautiously constructive. Of nine analysts, five rate the stock a Buy or equivalent, three maintain Hold ratings, and one assigns a Sell. JPMorgan's $26 target and Overweight rating represent the most visible bullish institutional endorsement, while Goldman Sachs' $43 target—though seemingly aspirational at current levels—reflects a high-conviction long-term view. On the cautious side, Barclays' $19 target and TD Cowen's Hold rating at $20 suggest that some analysts believe much of the growth potential is already balanced by execution risk. The average target of $25.25 sits almost exactly at the $25 level this article examines, implying that the consensus view treats $25 as a realistic but not guaranteed twelve-month destination.
Beyond the profitability question, OFRM faces several structural risks. The organic baby food market is increasingly competitive, with established players and private-label alternatives challenging the premium pricing that underpins Once Upon a Farm's brand. Supply chain disruptions and higher fuel surcharges—already cited as a 100-basis-point margin headwind—can erode the thin profitability cushion. Additionally, the company's small size, with just 153 employees and roughly $288 million in trailing revenue, means limited resources to absorb macroeconomic shocks or prolonged periods of elevated marketing spend required to build household penetration.
Navigating the volatility of a recently public growth stock like OFRM requires timely, data-driven decision-making. Tickeron's AI Daily Buy/Sell Signals leverage artificial intelligence to continuously scan thousands of stocks and ETFs, generating actionable Buy, Sell, or Hold signals based on evolving technical patterns, market conditions, and AI-powered analysis. Traders can use these signals to identify emerging opportunities, manage existing positions with greater confidence, and stay ahead of shifting market trends without manually monitoring every chart. For investors seeking an edge in a dynamic market, AI-driven signals offer a practical tool to complement traditional research.
The question of whether Once Upon a Farm (OFRM) can reach $25 is best answered with cautious optimism. The company's revenue growth story is compelling and supported by tangible drivers: expanding cooler placements, growing household penetration, and a product innovation pipeline that resonates with health-conscious parents. With Wall Street's average target sitting at approximately $25.25, the $25 level is firmly within the consensus range of achievable outcomes. However, the path from $16.70 to $25 is unlikely to be linear. The stock must overcome a persistent profitability deficit, a pattern of downward analyst revisions, and technical resistance in the low $20s. Investors should monitor gross margin trends, the pace of cooler deployments, and any inflection toward positive EBITDA as the most reliable signposts on the road to $25. While the bull case has merit, it ultimately depends on flawless execution in a competitive category with thin margins and high expectations.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.